$0.9576
-0.06-6.12%
At close: -
$0.9450
-0.01-1.32%
After Hours: Feb 21, 7:56 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Alzamend Neuro in recent months.
Browse guidance and forecast on all stocks.